6-((3R,4S)-4-(Azetidin-1-yl)-3-methylpiperidin-1-yl)-1-((R)-1-(2,4-dichlorophenyl)ethyl)-3-methyl-1H-pyrazolo[3,4-b]pyrazine

ID: ALA4556507

PubChem CID: 134324891

Max Phase: Preclinical

Molecular Formula: C23H28Cl2N6

Molecular Weight: 459.43

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1nn([C@H](C)c2ccc(Cl)cc2Cl)c2nc(N3CC[C@H](N4CCC4)[C@H](C)C3)cnc12

Standard InChI:  InChI=1S/C23H28Cl2N6/c1-14-13-30(10-7-20(14)29-8-4-9-29)21-12-26-22-15(2)28-31(23(22)27-21)16(3)18-6-5-17(24)11-19(18)25/h5-6,11-12,14,16,20H,4,7-10,13H2,1-3H3/t14-,16-,20+/m1/s1

Standard InChI Key:  FBEBMWSKPAYCSV-KKVAFCGZSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   29.0377  -27.5953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7477  -28.0126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4648  -27.6047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4702  -26.7753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.7524  -26.3555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0334  -26.7691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1869  -26.3643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9036  -26.7864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6239  -26.3742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.1899  -25.5386    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.9072  -25.1283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6266  -25.5420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2425  -24.9857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9037  -24.2280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.0785  -24.3163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.5255  -23.7041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7792  -22.9191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7189  -23.8769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1680  -23.2615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3621  -23.4338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1077  -24.2194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6656  -24.8329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4694  -24.6574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3014  -24.3933    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   30.4237  -22.4771    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   28.3242  -28.0070    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.7419  -28.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0497  -25.1559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5305  -27.7920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3171  -28.5877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1128  -28.8011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  8  9  1  0
  9 12  2  0
 11 10  2  0
 10  7  1  0
  4  7  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 19 25  1  0
  1 26  1  1
  2 27  1  1
 13 28  1  0
 26 29  1  0
 29 30  1  0
 30 31  1  0
 31 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4556507

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 459.43

Molecular Weight (Monoisotopic): 458.1753

AlogP: 4.97

#Rotatable Bonds: 4

Polar Surface Area: 50.08

Molecular Species: BASE

HBA: 6

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 9.11

CX LogP: 4.32

CX LogD: 2.60

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.55

Np Likeness Score: -1.15

References

1. Jackson JJ, Ketcham JM, Younai A, Abraham B, Biannic B, Beck HP, Bui MHT, Chian D, Cutler G, Diokno R, Hu DX, Jacobson S, Karbarz E, Kassner PD, Marshall L, McKinnell J, Meleza C, Okal A, Pookot D, Reilly MK, Robles O, Shunatona HP, Talay O, Walker JR, Wadsworth A, Wustrow DJ, Zibinsky M..  (2019)  Discovery of a Potent and Selective CCR4 Antagonist That Inhibits Treg Trafficking into the Tumor Microenvironment.,  62  (13): [PMID:31259550] [10.1021/acs.jmedchem.9b00506]

Source

Source(1):

• Scientific Literature